SNP-SNP interactions between DNA repair genes were associated with breast cancer risk in a Korean population

Cancer

Volumn 118, Issue 3, 2012, Pages 594-602

  Han, Wonshik ^a   Kim, Kyoung Yeon ^b   Yang, Song Ju ^c   Noh, Dong Young ^a   Kang, Daehee ^a   Kwack, Kyubum ^b  

^a Seoul National University   (South Korea)

^b CHA University   (South Korea)

^c Macrogen Inc   (South Korea)

Author keywords

breast cancer; DNA repair gene; gene gene interaction; genetic polymorphism; hormone receptor

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DNA REPAIR; ERCC1 GENE; ERCC2 GENE; EXCISION REPAIR; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; POPULATION RISK; PRIORITY JOURNAL; RPA1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREA; XPA GENE; XPC GENE;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA; DNA REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; ENDONUCLEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; RISK FACTORS; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 84856220925     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26220     Document Type: Article

References (30)

1. Bennett IC, Gattas M, Teh BT,. The management of familial breast cancer. Breast. 2000; 9: 247-263.
2. Chen YC, Hunter DJ,. Molecular epidemiology of cancer. CA Cancer J Clin. 2005; 55: 45-54.
3. Vispe S, Yung TM, Ritchot J, Serizawa H, Satoh MS,. A cellular defense pathway regulating transcription through poly(ADP-ribosyl)ation in response to DNA damage. Proc Natl Acad Sci U S A. 2000; 97: 9886-9891.
4. Helzlsouer KJ, Harris EL, Parshad R, Perry HR, Price FM, Sanford KK,. DNA repair proficiency: potential susceptiblity factor for breast cancer. J Natl Cancer Inst. 1996; 88: 754-755.
5. Shields PG, Harris CC,. Molecular epidemiology and the genetics of environmental cancer. JAMA. 1991; 266: 681-687.
6. Garcia-Closas M, Malats N, Real FX, et al. Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet. 2007; 3: e29.
7. Musani SK, Shriner D, Liu N, et al. Detection of gene x gene interactions in genome-wide association studies of human population data. Hum Hered. 2007; 63: 67-84.
8. Shen R, Fan JB, Campbell D, et al. High-throughput SNP genotyping on universal bead arrays. Mutat Res. 2005; 573: 70-82.
9. Wang N, Akey JM, Zhang K, Chakraborty R, Jin L,. Distribution of recombination crossovers and the origin of haplotype blocks: the interplay of population history, recombination, and mutation. Am J Hum Genet. 2002; 71: 1227-1234.
10. Lewis CM,. Genetic association studies: design, analysis and interpretation. Brief Bioinform. 2002; 3: 146-153.
11. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA,. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002; 70: 425-434.
12. Begg CB, Haile RW, Borg A, et al. Variation of breast cancer risk among BRCA1/2 carriers. JAMA. 2008; 299: 194-201.
13. Shen J, Terry MB, Gammon MD, et al. MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk. Carcinogenesis. 2005; 26: 2131-2137.
14. Matsuoka S, Huang M, Elledge SJ,. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science. 1998; 282: 1893-1897.
15. Lee KM, Choi JY, Kang C, et al. Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk. Clin Cancer Res. 2005; 11: 4620-4626.
16. Potter JD, Cerhan JR, Sellers TA, et al. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev. 1995; 4: 319-326.
17. Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003; 100: 8418-8423.
18. Ponder BA,. Cancer genetics. Nature. 2001; 411: 336-341.
19. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA,. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet. 2002; 31: 33-36.
20. Evans E, Moggs JG, Hwang JR, Egly JM, Wood RD,. Mechanism of open complex and dual incision formation by human nucleotide excision repair factors. EMBO J. 1997; 16: 6559-6573.
21. Krasikova YS, Rechkunova NI, Maltseva EA, et al. Interaction of nucleotide excision repair factors XPC-HR23B, XPA, and RPA with damaged DNA. Biochemistry (Mosc). 2008; 73: 886-896.
22. Bernard-Gallon D, Bosviel R, Delort L, et al. DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk. Mol Cancer. 2008; 7: 36.
23. Sehl ME, Langer LR, Papp JC, et al. Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer. Clin Cancer Res. 2009; 15: 2192-2203.
24. Zhu Y, Yang H, Chen Q, et al. Modulation of DNA damage/DNA repair capacity by XPC polymorphisms. DNA Repair (Amst). 2008; 7: 141-148.
25. Shen J, Desai M, Agrawal M, et al. Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer. Cancer Epidemiol Biomarkers Prev. 2006; 15: 1614-1619.
26. Robles AI, Wang XW, Harris CC,. Drug-induced apoptosis is delayed and reduced in XPD lymphoblastoid cell lines: possible role of TFIIH in p53-mediated apoptotic cell death. Oncogene. 1999; 18: 4681-4688.
27. Spitz MR, Wu X, Wang Y, et al. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res. 2001; 61: 1354-1357.
28. Flejter WL, McDaniel LD, Johns D, Friedberg EC, Schultz RA,. Correction of xeroderma pigmentosum complementation group D mutant cell phenotypes by chromosome and gene transfer: involvement of the human ERCC2 DNA repair gene. Proc Natl Acad Sci U S A. 1992; 89: 261-265.
29. Manuguerra M, Saletta F, Karagas MR, et al. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am J Epidemiol. 2006; 164: 297-302.
30. Bessho T, Sancar A, Thompson LH, Thelen MP,. Reconstitution of human excision nuclease with recombinant XPF-ERCC1 complex. J Biol Chem. 1997; 272: 3833-3837.